Dajun Yang
Chairman and CEO at Ascentage Pharma Group International
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: Ascentage Pharma Group International, 7 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Ascentage Pharma Group International | Option exercise | +95,575 | — | — |
| May 21, 2026 | Ascentage Pharma Group International | Option exercise | +92,746 | — | — |
Questions about Dajun Yang
What boards is Dajun Yang on?
Dajun Yang sits on the board of Ascentage Pharma Group International.
What company is Dajun Yang the CEO of?
Dajun Yang has been Chairman and CEO of Ascentage Pharma Group International since March 2026.
How long has Dajun Yang served on boards?
Our records show at least 7 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.